14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.87 $3.22 Friday, 3rd May 2024 PSTX stock ended at $2.87. This is 2.87% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.03% from a day low at $2.82 to a day high of $2.99.
90 days $1.87 $4.27
52 weeks $1.54 $4.27

Historical Poseida Therapeutics, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $2.83 $2.99 $2.82 $2.87 546 780
May 02, 2024 $2.86 $2.97 $2.74 $2.79 1 355 737
May 01, 2024 $2.69 $3.00 $2.69 $2.77 2 854 486
Apr 30, 2024 $2.29 $2.50 $2.27 $2.42 533 959
Apr 29, 2024 $2.15 $2.33 $2.13 $2.32 323 213
Apr 26, 2024 $2.03 $2.14 $2.03 $2.13 458 175
Apr 25, 2024 $2.03 $2.08 $1.98 $2.05 266 623
Apr 24, 2024 $2.13 $2.17 $2.02 $2.07 349 004
Apr 23, 2024 $2.16 $2.27 $2.12 $2.16 421 977
Apr 22, 2024 $2.03 $2.16 $2.00 $2.16 526 709
Apr 19, 2024 $2.00 $2.07 $1.95 $2.02 637 275
Apr 18, 2024 $2.05 $2.16 $2.00 $2.00 510 164
Apr 17, 2024 $2.03 $2.08 $1.91 $2.04 976 891
Apr 16, 2024 $2.12 $2.21 $1.87 $2.03 1 440 286
Apr 15, 2024 $2.71 $2.71 $2.42 $2.43 573 998
Apr 12, 2024 $2.92 $2.92 $2.66 $2.73 339 555
Apr 11, 2024 $2.82 $2.92 $2.75 $2.91 332 773
Apr 10, 2024 $2.93 $2.93 $2.77 $2.79 513 578
Apr 09, 2024 $2.99 $3.01 $2.88 $3.01 395 332
Apr 08, 2024 $3.05 $3.05 $2.93 $2.97 414 621
Apr 05, 2024 $3.04 $3.16 $2.98 $2.99 425 895
Apr 04, 2024 $3.06 $3.22 $3.04 $3.07 371 759
Apr 03, 2024 $2.90 $3.10 $2.88 $3.06 443 266
Apr 02, 2024 $3.01 $3.04 $2.87 $2.90 421 289
Apr 01, 2024 $3.29 $3.35 $3.03 $3.10 531 306
Click to get the best stock tips daily for free!

About Poseida Therapeutics, Inc.

Poseida Therapeutics. Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patient... PSTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT